Status:
NOT_YET_RECRUITING
Prevention of ANxiety and Depression Over Risk Assessment
Lead Sponsor:
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Collaborating Sponsors:
European Regional Development Fund
Research Network on Chronicity, Primary Care, and Health Promotion
Conditions:
Depression
Anxiety
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The general goal is to design, develop and evaluate a personalized, self-guided and trans-diagnostic internet-based intervention to prevent anxiety and depression, based on predictive risk algorithms ...
Detailed Description
The specific goals are: 1) to adapt the epD-Work App (an App developed to prevent depression in the workplace with predictive risk algorithms, decision support system, monitoring and feedback, reposit...
Eligibility Criteria
Inclusion
- Informed consent acceptance
- Having a valid telephone number
- Ownership of an Apple-Android-operating smartphone with an internet connection
- 18-65 years old
- Habitually reside (\> 6 months/year) in Spain or Chile
Exclusion
- Difficulty reading and/or understanding Spanish
- Suffer from disabling neurological conditions (dementia, blindness, etc.) that makes it difficult to use smartphone, terminal illness with a life expectancy \< 12 months, a history of severe mental disorders confirmed by a healthcare professional (schizophrenia or psychosis, bipolar, anoxeria, bulimia or personality disorders), having alcohol or substance use disorder within the past year
- Currently receiving face to face or via internet psychological treatment (currently taking antidepressants or anxiolytics is not an exclusion criterion, but their use will be taken into account throughout the follow-up)
- Presence of clinically relevant anxiouys (GAD-7 score ≥ 10 points) or depressive symptoms (PHQ-9 score ≥ 10 points).
Key Trial Info
Start Date :
February 15 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 7 2028
Estimated Enrollment :
2595 Patients enrolled
Trial Details
Trial ID
NCT07185867
Start Date
February 15 2026
End Date
March 7 2028
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Juan Ángel Bellón Saameño
Málaga, Málaga, Spain